In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...
Hosted on MSN
The reality of animal testing today
Today’s animal testing differs from how it was back in the day. It’s typically done on a specific ingredient rather than a finished product, and there are often regulatory requirements based on ...
FIRST ON FOX — The Food and Drug Administration is phasing out an animal testing requirement for antibody therapies and other drugs in favor of testing on materials that mimic human organs, the FDA ...
A vast number of chemicals are registered for production and use around the world. But only a portion have been thoroughly evaluated for their toxicity due to time, cost, ethical concerns and ...
The U.S. Food and Drug Administration (FDA) on Dec. 2, 2025, issued its draft guidance on Monoclonal Antibodies: Streamlined Nonclinical Safety Studies Guidance for Industry, the agency's most recent ...
Stem Pharm, a Madison biotech startup, is using lab-created 3D "organoids" to develop a treatment for Alzheimer's disease. In April, the FDA and NIH announced plans to incentivize so-called "new ...
VivoSim Labs has launched non-animal toxicology models to enhance drug development, aligning with FDA's initiative to phase out animal testing. VivoSim Labs, Inc. has officially launched after ...
Lorna Ewart has long been frustrated by the mismatch between animal and human toxicity data. All too often preclinical studies in rats and dogs will suggest a drug is safe, only for clinical trial ...
A microscopic model of the human liver to study the effects of different food contaminants. The spherical model, measuring 0.3 mm in diameter, includes the four cell types found in the human liver.
Millions of animals each year are killed in U.S. laboratories as part of medical training and chemical, food, drug and cosmetic testing, according to the non-profit animal rights organization People ...
Schrödinger’s stock surged after the FDA's initiative to phase out animal testing, benefiting its computational drug discovery platform. The company has strong collaborations with big pharma and a ...
Professor of Chemical and Biological Engineering, Biomedical Engineering, and Public Health, Colorado State University A vast number of chemicals are registered for production and use around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results